MoneyWorks4Me

Indoco Remedies - Quaterly Results

22 May 2025 Evaluate
A decrease in the sales to Rs. 3472.50 millions was observed for the quarter ended March 2025. The sales stood at Rs. 4454.90 millions during the similar quarter previous year.The Net Loss for the quarter ended March 2025 is Rs. -262.40 millions as compared to Net Profit of Rs. 375.60 millions of corresponding quarter ended March 2024A decline of 99.60 millions was observed in the OP in the quarter ended March 2025 from 614.10 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 3472.50 4454.90 -22.05 15181.90 17908.10 -15.22 15181.90 17908.10 -15.22
Other Income 65.00 40.50 60.49 184.80 85.10 117.16 184.80 85.10 117.16
PBIDT 99.60 614.10 -83.78 1465.20 2664.90 -45.02 1465.20 2664.90 -45.02
Interest 159.80 109.10 46.47 566.30 368.20 53.80 566.30 368.20 53.80
PBDT -60.20 702.30 -108.57 908.80 2412.00 -62.32 908.80 2412.00 -62.32
Depreciation 248.80 237.30 4.85 982.50 879.80 11.67 982.50 879.80 11.67
PBT -309.00 465.00 -166.45 -73.70 1532.20 -104.81 -73.70 1532.20 -104.81
TAX -46.60 89.40 -152.13 13.60 365.80 -96.28 13.60 365.80 -96.28
Deferred Tax -17.30 -15.20 13.82 13.60 38.10 -64.30 13.60 38.10 -64.30
PAT -262.40 375.60 -169.86 -87.30 1166.40 -107.48 -87.30 1166.40 -107.48
Equity 184.50 184.40 0.05 184.50 184.40 0.05 184.50 184.40 0.05
PBIDTM(%) 2.87 13.78 -79.19 9.65 14.88 -35.15 9.65 14.88 -35.15
Peers
Company Name CMP
Sun Pharma. Inds. 1844.00
Dr. Reddys Labs. 1212.00
Cipla 1381.00
Lupin 2120.10
Zydus Lifesciences 1161.00
View more..